This paracrine action was found to be dependent on the aggressiveness of the breast cancer cell lines investigated, with the triple-negative MDA-MB-231 cells resulting in syndecan-1 overexpression, while the low-invasive MCF-7 cells had no effect. The gene discussed is SDC1; the disease is breast carcinoma.